We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Postpartum Opioid Prescribing Patterns and Patient Utilization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03030742
Recruitment Status : Completed
First Posted : January 25, 2017
Last Update Posted : February 25, 2020
Sponsor:
Collaborator:
Society for Maternal-Fetal Medicine
Information provided by (Responsible Party):
Lynn M Yee, Northwestern University

Tracking Information
First Submitted Date January 23, 2017
First Posted Date January 25, 2017
Last Update Posted Date February 25, 2020
Actual Study Start Date June 1, 2017
Actual Primary Completion Date August 30, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: January 23, 2017)
Postpartum outpatient opioid use [ Time Frame: 8 weeks ]
Self reported number of opioid tablets used at time of postpartum survey administered 2-4 weeks postpartum
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: January 23, 2017)
  • Satisfaction with outpatient pain control [ Time Frame: 8 weeks from time of hospital discharge ]
    Satisfaction with pain control at the time of postpartum survey administered 2-4 weeks postpartum
  • Proper disposal/storage of remaining opioid tablets [ Time Frame: 8 weeks from time of discharge ]
    Proportion of patients who report proper disposal/storage of remaining opioid tablets at the time of postpartum survey administered 2-4 weeks postpartum
  • High opioid use [ Time Frame: 8 weeks from time of hospital discharge ]
    Comparison of characteristics of women with >50% remaining versus <50% remaining of prescribed opioid tablets
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Postpartum Opioid Prescribing Patterns and Patient Utilization
Official Title Postpartum Opioid Prescribing Patterns and Patient Utilization
Brief Summary This study seeks to investigate the prescribing patterns and patient utilization of opioid pain medication in the postpartum setting. Postpartum women will be surveyed prior to hospital discharge and again at 2-4 weeks postpartum in order to assess the number of opioid tablets they used (in relation to the number prescribed), pain satisfaction, and storage/disposal of any remaining opioid tablets.
Detailed Description

Opiate abuse is a national epidemic and has paralleled the increase in opioid prescriptions, with diversion of surplus medication playing a key contributing role. As the majority of reproductive age women in the U.S. will experience childbirth, understanding opioid prescription patterns and patient opioid utilization in the postpartum period is critical.

Postpartum women will be recruited during a 9-month period to take part in pre-hospital discharge and 2-4 week postpartum surveys to prospectively assess opioid medication use with regard to quantity of opioid tablets prescribed and quantity used, storage and disposal of unused opioids and satisfaction with pain control.

Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Women who are postpartum
Condition
  • Postpartum
  • Opioid Use
  • Post-operative
  • Cesarean Delivery
Intervention Other: Survey

A survey will be administered at two time points (time of hospital discharge and 2-4 weeks postpartum) to determine:

  • Satisfaction with pain control 2-4 weeks postpartum
  • Patient-reported use of opioid medication postpartum (receipt of prescription, filling of prescription, if refill was obtained, and number of opioid pills remaining at the time of follow-up)
  • Patient characteristics associated with high opioid use
  • Methods of storage and disposal of unused opioids
Other Name: Survey/Questionnaire
Study Groups/Cohorts
  • Post-cesarean delivery
    Women who have undergone cesarean delivery
    Intervention: Other: Survey
  • Post-vaginal delivery
    Women who have undergone vaginal delivery
    Intervention: Other: Survey
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: February 24, 2020)
494
Original Estimated Enrollment
 (submitted: January 23, 2017)
700
Actual Study Completion Date December 31, 2019
Actual Primary Completion Date August 30, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Women who deliver during the recruitment period
  • English-speaking
  • Opiate-naïve (as determined by admission medication reconciliation)
  • Receive oral opioid medications during inpatient postpartum admission
  • 18 years or older

Exclusion Criteria:

  • Contraindication to NSAID use
  • Required use of general anesthesia without concurrent neuraxial analgesia
  • Undergo hysterectomy, or unanticipated surgical procedures during the postpartum period
  • Are admitted to the intensive care unit during their admission.
Sex/Gender
Sexes Eligible for Study: Female
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers Not Provided
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT03030742
Other Study ID Numbers NortherwesternU
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: No
Current Responsible Party Lynn M Yee, Northwestern University
Original Responsible Party Same as current
Current Study Sponsor Northwestern University
Original Study Sponsor Same as current
Collaborators Society for Maternal-Fetal Medicine
Investigators
Principal Investigator: Nevert Badreldin, MD Northwestern University
PRS Account Northwestern University
Verification Date February 2020